Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 702-708, March 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lucis, O. J.
Right arrow Articles by Lucis, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lucis, O. J.
Right arrow Articles by Lucis, R.

Conversion of Dehydroepiandrosterone, Pregnenolone, and Progesterone by Interstitial Cell Tumor Tissue1

O. J. Lucis and R. Lucis

Department of Pathology, Pathology Institute, Halifax, Nova Scotia, Canada

Steroid biosynthesis was studied in a spontaneous mouse interstitial cell tumor grown as a transplant in isologous male recipients. In timed incubations the tumor tissue rapidly transformed dehydroepiandrosterone to androstenedione. The formation of testosterone, 11ß-hydroxyandrostenedione, and 11ß-hydroxytestosterone proceeded at a slower rate. A conversion product with chromatographic characteristics of 19-hydroxyandrostenedione was also found. Incubation of tumor tissue with equal weights of 3H-labeled pregnenolone and 14C-labeled progesterone resulted in formation of dual-labeled progesterone, 17{alpha}-hydroxyprogesterone, androstenedione, testosterone, 11-deoxycorticosterone, corticosterone, and 20{alpha}-hydroxypregn-4-en-3-one. A dual-labeled compound with characteristics of 11ß-hydroxyprogesterone was also detected. The tumor tissue in its steroid biosynthetic properties partly resembled testis tissue and partly resembled adrenocortical tissue. Dual-labeled conversion products showed variations in their 3H:14C ratios which may be attributed to heterogeneity of the tumor cell population and their differences in activities of steroid-transforming enzymes.

1 This study was supported by grants from the National Cancer Institute of Canada and the Medical Research Council of Canada.

Received 6/13/69. Accepted 8/ 6/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.